Proteome profiling of peripheral mononuclear cells from human blood

Proteomics

Volumn 13, Issue 5, 2013, Pages 893-897

  Maccarrone, Giuseppina ^a   Rewerts, Christiane ^a   Lebar, Maria ^a   Turck, Christoph W ^a   Martins de Souza, Daniel ^a,b,c  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; Biomedicine; Blood; Diseases; Mononuclear cells; Shotgun

Indexed keywords

PROTEOME;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; DISEASE COURSE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR MECHANICS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; BLOOD PROTEINS; DATABASES, PROTEIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDE MAPPING; PROTEOME; PROTEOMICS;

EID: 84874808362     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200377     Document Type: Article

References (25)

1. Kapsogeorgou, E. K., Gourzi, V. C., Manoussakis, M. N., Moutsopoulos, H. M. et al., Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J. Autoimmun. 2011, 37, 129-135.
2. Mesko, B., Poliska, S., Nagy, L., Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases. Trends Mol. Med. 2011, 17, 223-233.
3. Zhang, Z., Li, Y., Guan, X., Yang, X. et al., Human leukocyte antigen class I on peripheral blood mononuclear cells as a non-invasive biomarker for esophageal cancer. Dis. Esophagus 2012, 25, 273-278.
4. Pasinetti, G. M., Fivecoat, H., Ho, L., Personalized medicine in traumatic brain injury. Psychiatr. Clin. North Am. 2010, 33, 905-913.
5. Fuss, I. J., Kanof, M. E., Smith, P. D., Zola, H., Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protoc. Immunol. 2009, Chapter 7, Unit7 1. doi: 10.1002/0471142735.im0701s85.
6. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
7. Barsnes, H., Vizcaino, J. A., Eidhammer, I., Martens, L., PRIDE converter: making proteomics data-sharing easy. Nat. Biotechnol. 2009, 27, 598-599.
8. Vizcaino, J. A., Cote, R., Reisinger, F., Foster, J. M. et al., A guide to the Proteomics Identifications Database proteomics data repository. Proteomics 2009, 9, 4276-4283.
9. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
10. Thomas, P. D., Kejariwal, A., Campbell, M. J., Mi, H. et al., PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 2003, 31, 334-341.
11. Martins-de-Souza, D., Guest, P. C., Steeb, H., Pietsch, S. et al., Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry. Proteomics 2011, 11, 2347-2353.
12. Martins-de-Souza, D., Maccarrone, G., Reckow, S., Falkai, P. et al., Shotgun mass spectrometry analysis of the human thalamus proteome. J. Sep. Sci. 2009, 32, 1231-1236.
13. Li, C., Xin, W., Sy, M. S., Binding of pro-prion to filamin A: by design or an unfortunate blunder. Oncogene 2010, 29, 5329-5345.
14. Masruha, M. R., Caboclo, L. O., Carrete, H., Jr., Cendes, I. L. et al., Mutation in filamin A causes periventricular heterotopia, developmental regression, and West syndrome in males. Epilepsia 2006, 47, 211-214.
15. Sun, Y., Almomani, R., Aten, E., Celli, J. et al., Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene. Am. J. Hum. Genet. 2010, 87, 146-153.
16. Degroote, R. L., Hauck, S. M., Kremmer, E., Amann, B. et al., Altered expression of talin 1 in peripheral immune cells points to a significant role of the innate immune system in spontaneous autoimmune uveitis. J. Proteomics 2012, 75, 4536-4544.
17. Kanamori, H., Kawakami, T., Effendi, K., Yamazaki, K. et al., Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma. Oncology 2011, 80, 406-415.
18. Zemljic-Harpf, A., Manso, A. M., Ross, R. S., Vinculin and talin: focus on the myocardium. J. Investig. Med. 2009, 57, 849-855.
19. Milewicz, D. M., Kwartler, C. S., Papke, C. L., Regalado, E. S. et al., Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet. Med. 2010, 12, 196-203.
20. Cox, B., Emili, A., Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. 2006, 1, 1872-1878.
21. Fatimathas, L., Moss, S. E., Annexins as disease modifiers. Histol. Histopathol. 2010, 25, 527-532.
22. Martins-de-Souza, D., Harris, L. W., Guest, P. C., Bahn, S., The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid. Redox. Signal 2011, 15, 2067-2079.
23. Holkova, B., Grant, S., Proteasome inhibitors in mantle cell lymphoma. Best Pract. Res. Clin. Haematol. 2012, 25, 133-141.
24. Schipper-Krom, S., Juenemann, K., Reits, E. A., The ubiquitin-proteasome system in Huntington's disease: are proteasomes impaired, initiators of disease, or coming to the rescue? Biochem. Res. Int. 2012, 2012, doi:10.1155/2012/837015.
25. Martins-de-Souza, D., Is the word 'biomarker' being properly used by proteomics research in neuroscience? Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260, 561-562.